Characterising the castration-resistant prostate cancer population: a systematic review
The Prostate Centre · AstraZeneca (United Kingdom) · +3 more institutions
Abstract
Castration-resistant prostate cancer (CRPC) is an advanced form of prostate cancer associated with poor survival rates. However, characterisation of the disease epidemiology is hampered by use of varying terminology, definition and disease management. The aim of this review was to conduct a systematic review to provide greater clarity on the sum of the available epidemiologic evidence and to guide future research into the disease prevalence, progression, characteristics and outcome.
Systematic searches of PubMed and Embase were performed in March 2010 to identify relevant observational studies relating to the epidemiology, progression and outcomes of CRPC. Further studies were identified for inclusion in our review through manual searches of the authors' bibliographical databases and the reference lists of the included articles.
Citation impact
- FWCI
- 16.06
- Percentile
- 100%
- References
- 27
Authors
3Topics & keywords
- Medicine
- Prostate cancer
- Oncology
- Gynecology
- MEDLINE
- Castration
- Population
- Cancer
- Good health and well-being